Medacta USA, Inc.
Brad Bolinger is an experienced executive in the medical device industry, currently serving as CEO/Owner of The Daltons Inc. since June 2020, while also working as a Strategic Consultant for Medacta USA, Inc. and an Advisor for AcuityMD. From March 2018 to March 2020, Brad held the position of Vice President & General Manager - US Sales at Zimmer Biomet, overseeing a substantial division with significant sales figures. Prior roles include Senior Director of Sales for DJO Surgical and General Manager at Stryker Orthopaedics, where Brad demonstrated expertise in sales management and strategic planning. Early career experiences include positions in sales with Zimmer and Bayer, as well as coaching roles at Northwestern University and Miami University. Brad Bolinger earned a Bachelor of Arts in Education with a focus on Physical Education and athletic training from Franklin College.
This person is not in any offices
Medacta USA, Inc.
2 followers
Medacta USA is a subsidiary of Medacta International, a company specializing in the design, production, and distribution of innovative orthopaedic products, as well as in the development of accompanying surgical techniques. Established in 1999 in Switzerland, Medacta is active in joint replacement, spine surgery, and sports medicine. Medacta is committed to improving the care and well-being of patients and maintains a strong focus on healthcare sustainability. Medacta’s innovation, forged by close collaboration with surgeon leaders globally, began with minimally invasive surgical techniques and has evolved into personalized solutions for every patient. Through the M.O.R.E. Institute, Medacta supports surgeons with a comprehensive and tailored program dedicated to the advancement of medical education. Medacta is headquartered in Castel San Pietro, Switzerland, and operates in over 40 countries. Medacta USA is headquartered in Franklin, Tennessee.